MSB 4.89% $1.07 mesoblast limited

Ann: DSMB Analysis Recommends to Continue P3 COVID-19 ARDS Trial, page-374

  1. 7,533 Posts.
    lightbulb Created with Sketch. 6795
    1870 now is the US daiily deaths tally for today. I am really started to get frustrated now by the tardiness of NIH. THis trial should have been done and dusted by now. REM_L, presuming it is efficacious, out there saving lives, rather than the crappy anti-virals and other treatments doing nothing. If you understand the pathogenisis of COVID-19 ARDS and the mechanisms of REM-L in reversing cyctokine storms you cannot help but believe it can save countless otherwise lost lives.

    That people believe the vaccine is going to immediately save the day is a sad reflection of the lack of perspective people have. 60% of Americans said they will get a vaccine in November. That ones a little like only 30% of people said they'd vote for Trump. It will be 50% at test and it will not be before end of 2021 in the US alone. I am buying into any MSB dips....
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.07
Change
-0.055(4.89%)
Mkt cap ! $1.255B
Open High Low Value Volume
$1.14 $1.16 $1.07 $7.061M 6.409M

Buyers (Bids)

No. Vol. Price($)
13 24842 $1.07
 

Sellers (Offers)

Price($) Vol. No.
$1.08 126205 21
View Market Depth
Last trade - 15.27pm 29/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.